Healthcare / Medical Care FacilitiesHKSE
$0.46
+0.00 (+1.10%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $107.0M · quality 67.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
30/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$460M
P/E
23.0x
↑EV/EBITDA
7.7x
↓ROE
5.0%
↑Gross Margin
93.6%
↑Debt/Equity
0.76
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-0.3%
FCF CAGR
+17.5%
FCF margin
22.4%
FCF / Net income
3.25x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $317.1M · net income $21.9M · FCF $71.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $317.1M | $317.1M | $271.3M | $408.3M | $320.3M |
| Net Income | $21.9M | $21.9M | $64.2M | $126.2M | $98.9M |
| EBITDA | $96.8M | $96.8M | $133.6M | $206.9M | $161.7M |
| EPS | 0.02 | 0.02 | 0.06 | 0.13 | 0.10 |
| Gross Margin | 93.6% | 93.6% | 93.9% | 96.1% | 95.5% |
| Operating Margin | 20.2% | 20.2% | 21.1% | 36.8% | 36.9% |
| Net Margin | 6.9% | 6.9% | 23.7% | 30.9% | 30.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.76 | 0.76 | 0.88 | 0.72 | 1.01 |
| Current Ratio | 1.00 | 1.00 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $71.1M | $71.1M | $108.1M | $107.0M | $43.8M |
| Returns | |||||
| ROE | 5.0% | 5.0% | 14.8% | 33.9% | 33.9% |
| Valuation | |||||
| P/E | 23.00 | 23.00 | 8.72 | 4.83 | 6.47 |
| EV/EBITDA | 7.66 | 7.66 | 6.79 | 3.91 | 5.46 |
| P/B | 1.05 | 1.05 | 1.29 | 1.64 | 2.20 |
| Growth & Yield | |||||
| Revenue Growth | 16.9% | 16.9% | -33.5% | 27.5% | — |
| EPS Growth | -65.9% | -65.9% | -49.1% | 27.6% | — |
| Dividend Yield | 4.3% | 4.3% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
23.1%
EPS terminal req.
$0.04
Spread vs growth
-89.0%
5Y implied EPS CAGR
17.7%
EPS terminal req.
$0.05
Spread vs growth
-83.6%
10Y implied EPS CAGR
13.8%
EPS terminal req.
$0.08
Spread vs growth
-79.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+1.2%
Start / end P/E
7.4x → 21.0x
EPS bridge
0.06 → 0.02
Residual
-121.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.